Engrave Wealth Partners LLC Pfizer Inc Transaction History

Engrave Wealth Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 08, 2020	SELL	$31.75 - $37.25 $104,171 - $122,217	-3,281 Closed	0 $0
Q2 2020 Jul 14, 2020	SELL	$30.12 - $36.54 $13,403 - $16,260	-445 Reduced 11.94%	3,281 $107,000
Q1 2020 Apr 20, 2020	SELL	$27.03 - $38.62 $25,462 - $36,380	-942 Reduced 20.18%	3,726 $121,000
Q4 2019 Mar 12, 2020	BUY	$32.92 - $37.36 $153,670 - $174,396	4,668 New	4,668 $182,000

3,253

3.72B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Engrave Wealth Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Engrave Wealth Partners LLC with notifications on news.